The last 24 months have been anything but normal. An extreme divide formed between COVID “winners” and “losers”, while unimaginable levels of stimulus supported broad asset prices and fueled intense speculation.
2022 is different. A marked shift in future inflation, interest rates and liquidity expectations has resulted in an aggressive market sell-off, and an even- more-aggressive market rotation to low valuation (“Value”) stocks. January 2022 was the second worst month for Growth stocks looking back over the past 20 years (Fig. 1).
The volatile start to the year in financial markets is unlikely to abate soon. Sustained inflation, a looming Federal Reserve (Fed) rate hiking cycle, tightening liquidity conditions, and the unwinding of pandemic era economic distortions — among other factors— mean that further price fluctuations can be expected. While it is too early to say that we are in a post-COVID world, the world has made significant progress and we see a pathway to living with the virus. This would be positive for normalising supply chain pressures (key to alleviating this absurd supply- driven inflation), but as we have learned through COVID, the future is anything but certain.
January 22 – New expectations catalyse a wild rotation
In January we witnessed an historic rotation to Value stocks as it became clear inflation was a bigger problem than expected. In response, expectations for US Federal Reserve rate hikes increased dramatically, while US nominal and real yields moved sharply higher, back to their highest level since early 2020. Global equity markets responded with a sharp 5% fall, with lofty valuations increasingthe market’s sensitivity to an adjusted rate outlook. Low quality, “deep value” stocks outperformed meaningfully and we witnessed strong divergence between sector and style returns (Fig. 2).
Our Global Growth Equity strategy focuses on quality, durable growth companies, with a 2-3 year return horizon; this was not a month for our preferred companies. While we experience adverse market conditions from time to time, the sheer speed and size of the market’s rotation to lower quality companies resulted in higher underperformance than we would expect in any one single month, with positioning across the higher innovation sectors of Consumer Discretionary, Information Technology and Health Care detracting the most from returns, while no exposure to the strong-performing Energy sector also worked against the portfolio. It is important to remain humble about economic developments from here, but we see a rotation as we witnessed in January as a one-time rebasing of expectations, not a likely reoccurrence in 2022. Broad sweeping rotations such as we experienced in January tend to result in indiscriminate selling. This volatility often presents opportunity in companies whose outlook we still believe remains strong – historically this mispricing has presented us with opportunities, and we see this period as no different.
Inflation – a sticky problem?
As we step forward in 2022, we believe inflation will decline from its unsustainably high and distorted current levels. Used cars and oil are unlikely repeat their step-change support to inflation, while persisting supply chain pressures will continue to add pressure. The combination of persistent and transitory inflation inputs will see inflation fall to lower- than-current levels but settle higher than the pre-COVID environment in our view. Our base case is that this is an environment which will prevent interest rates moving too high and support continued economic growth. As a bottom-up stock picker, we are avoiding trying to be too precise (while acknowledging the importance for markets) and focusing more on the individual impacts these inflationary pressures are having on company margins.
Growth vs Value – separating the short and long term
This changed following Pfizer’s initial vaccine data release in Nov 2020 – expectations of a Pandemic “cure” coupled with inflation’s persistence have driven Value to outperform by more than 20% since 9 Nov 2020. Attempting to call the direction of Growth or Value in the near term is incredibly difficult – this requires informed and high conviction views on COVID cases/variants, pandemic normalization, supply chain pressures, inflation, central bank reactions, real economy strength (plus more)- these are all unprecedented and incredibly uncertain.
The challenge investors have today, is separating long term expected returns from short term narratives. As we consider the future from where we sit today, we believe the world will be more similar to its pre-pandemic self than not. While some forces which have supported Growth appear to have shifted, such as peaking globalisation, our base case is that supply chains will normalize as we learn to live with COVID, inflation will revert back to a lower, manageable range, interest rates will rise but are likely to level out at levels we were used to pre-pandemic, and that overall economic growth will remain positive, but slow. In a new world which has adopted a shift to technology like no other period in history, we believe this environment will support the fundamental outperformance of Growth stocks, but this a longer-term view that won’t be the narrative of 2022. The challenge is, are you a long-term or short-term investor? Mistiming these short-term shifts can be challenging, hence our framework which focuses on fundamentals over 2-3 year horizons.
Navigating the uncertainty
As pandemic extremes continue to find a path of normalization, we retain our 2021 approach of positioning the portfolio in the “middle of the fairway” and focusing on idiosyncratic stock picking. Heightened uncertainty remains and this is not the time, in our view, to make portfolio-defining shifts in either direction.
At the stock level, we are observing a broader opportunity set than we have for some time – innovative, high growth companies trading at more reasonable valuations, reopening opportunities in travel and recreation, companies whose supply-chain-induced margin pressures are reversing, and idiosyncratic opportunities not tied to broader market forces. After the recent sell-off, we are at a point where risk-reward looks strong in our view. With inflation pressures remaining and appearing more persistent in the near-term, we retain our exposure to Financials and Real Estate but are carefully managing our weights in light of recent outperformance. We will however not compromise our hurdles for companies and may underperform should low quality, leveraged cyclicals outperform.
Acknowledging extremes and the unknowable requires humility and patience but combining this with experience and deep insights across sectors and regions positions us well to pursue the opportunities we expect to emerge. Our portfolio continues to represent the highest conviction ideas from our global research platform, diversified across companies, sectors and regions. This has served us well, for delivering investors strong and consistent outperformance since inception.
